NEW YORK (GenomeWeb) – Waters today reported that its fourth quarter revenues were up 7 percent compared to the year-ago period.

For the three months ended Dec. 31, 2016, Waters' total revenues increased to $628.8 million from $586.6 million in Q4 2015, besting the consensus analyst estimate of $615.9 million.

The effect of foreign currency translation reduced Q4 revenues by 2 percent, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.